TELA Bio (TELA) Consolidated Net Income (2018 - 2026)

TELA Bio has reported Consolidated Net Income for 9 years, with the latest figure at -$11.3 million in Q2 2026.

• On a quarterly basis, Consolidated Net Income fell 13.49% year-over-year to -$11.3 million in Q2 2026; TTM through Jun 2026 was -$33.4 million, a 19.57% increase from a year earlier, with the FY2025 full-year figure at -$31.1 million, down 1.4% from the prior year.
• Consolidated Net Income was -$11.3 million for Q2 2026 at TELA Bio, up from -$12.3 million in the prior quarter.
• The five-year high for Consolidated Net Income was -$1.3 million in Q4 2025, with the low at -$13.6 million in Q4 2023.
• Average Consolidated Net Income over 5 years is -$10.3 million, with a median of -$11.0 million recorded in 2022.
• The largest YoY upside for Consolidated Net Income was 87.34% in 2025 against a maximum downside of 98.98% in 2025.
• Over 5 years, Consolidated Net Income stood at -$10.6 million in 2022, then retreated by 28.36% to -$13.6 million in 2023, then increased by 26.84% to -$10.0 million in 2024, then jumped by 87.34% to -$1.3 million in 2025, then slumped by 792.39% to -$11.3 million in 2026.
• The last three Consolidated Net Income figures came in at -$11.3 million (Q2 2026), -$12.3 million (Q1 2026), and -$1.3 million (Q4 2025), per Business Quant data.